The second meeting between Eleanor Mercier and Adrian Voss took place not in the visiting room but in a small conference room adjacent to the warden's office. The room had a table, four chairs, and a window that looked out onto the prison yard. No Plexiglas this time. Mercier had called in a favor from a former colleague who now worked in the Bureau of Prisons, and the favor had materialized in the form of a "legal consult" designation that allowed Voss to meet with her as a potential witness rather than as an inmate.
Voss sat across from her, his hands resting on the table. He looked thinner than he had a week ago, the bones of his wrists more pronounced beneath the orange fabric of his jumpsuit. But his eyes were alert, and when Mercier told him about the Durham server—about the empty room, the recycling center, the forty-eight-hour shredding window—he did not look surprised.
"I expected that," he said. "The question is what they're protecting now, not what they protected then."
"The new drug," Mercier said. "Avantix."
"Yes. CX-903 was the prototype. Avantix is the finished product. Same mechanism, slightly modified molecular structure to avoid the toxicity issues I identified. But the clinical data they submitted to the FDA shows an efficacy profile that doesn't make sense unless they had human data to refine the formulation. They needed to know how the compound behaved in actual cardiac patients. Old patients, with multiple comorbidities, taking multiple medications. The exact population you'd find in a nursing home."
Mercier nodded. She had reached the same conclusion. "The FDA application for Avantix cites Phase II trial results from a site in Eastern Europe. I checked. The site exists, but the enrollment numbers don't match the data output. They ran more subjects than they reported, and they ran them somewhere else."
"Larkspur Rest."
"Larkspur and at least two other facilities in the Evergreen chain. I found a pattern—eighteen deaths across three nursing homes, all cardiac, all signed by Dr. Leland Bryce, all within the same eighteen-month window. The tissue samples from the coroner are at Quantico now, but the lab says the compounds they'd need to test for have a short half-life. After this much time, detection is uncertain."
Voss leaned back in his chair. "You don't need the tissue samples. You need the financial records."
Mercier looked at him sharply. "Explain."
"Kaelstrom is a publicly traded company. They can't hide large expenditures. If they ran an illegal clinical trial, someone paid for it. The drugs, the equipment, the data management, the payments to Evergreen for access to the patients—it all flows through the accounting department. Follow the money. It's the oldest advice in law enforcement for a reason."
"The money will be hidden. Shell companies, offshore accounts."
"Probably. But Margaret Cho isn't hidden. You said she was the CFO of Evergreen, and before that she worked at Kaelstrom. She's the bridge between the two organizations. She knows where the money went because she moved it herself."
Mercier was silent for a moment. She had already requested Margaret Cho's financial records, but the request was crawling through the Treasury Department's bureaucracy at the usual pace. She needed something faster.
"What about the compassionate release motion?" she asked.
Voss's expression flickered. "Hirsch filed it. The lawyer who visited me. They want me out of here, somewhere quiet where I can't cause trouble. The hearing is scheduled for next week."
"If you're released, you'll be a free man. You could walk away from all of this."
"I could. But I won't."
"Why not?"
"Because I helped build the molecule that killed those people. I didn't know what they were going to do with it, but I built it. That's not guilt in the legal sense. It's something else. Something I have to carry regardless of where I sleep at night."
Mercier studied him. In her experience, men in prison said many things to impress federal agents. They claimed innocence, offered information, promised cooperation, all in the hope of reducing their sentences or improving their conditions. But Voss had already been offered a way out, and he had refused it. Whatever was driving him, it was not self-interest.
She made a decision. "I'm going to tell you something that I shouldn't. The Bureau is not opening a formal investigation into Kaelstrom. My supervisor reviewed my preliminary findings and concluded that there is insufficient evidence to establish probable cause for a criminal inquiry. The FDA is reviewing Avantix on an accelerated timeline, and there is pressure from Washington to approve the drug. It's an election year. The administration wants a healthcare win."
Voss absorbed this without visible reaction. "So it's over."
"It's not over. But I can't do this through official channels anymore. I've been told to close my inquiry and return to my assigned caseload. If I continue investigating Kaelstrom, I'll be in violation of a direct order."
The words hung in the air between them. Mercier had never said anything like this to anyone. She had spent her entire career inside the lines, following procedures, building cases that could withstand scrutiny because they had been built correctly. What she was contemplating now was something else entirely.
"There's another copy of the data," Voss said quietly.
Mercier looked up. "You said the Durham server was the only backup."
"I lied. Not to you—to Hirsch. I told him about Durham because I knew he would destroy it. I needed to see how fast he would move. The speed of his response told me two things. First, that the data was real and dangerous. Second, that there was something else he was even more afraid of."
"What?"
"Leland Bryce kept his own records. I know this because I knew Bryce before I was arrested. He was meticulous to the point of paranoia. He documented everything—meetings, decisions, data. He believed that if the company ever turned on him, his records would be his insurance policy. He stored them on a personal server, not connected to the Kaelstrom network. I don't know where the server is, but I know it exists."
Mercier felt a surge of adrenaline. "Why would Bryce keep records of an illegal trial? That would incriminate him."
"Because Bryce didn't see it as illegal. He saw it as necessary. The FDA approval process is slow and expensive. Patients die waiting for drugs that could save them. Bryce believed he was accelerating a treatment that would benefit thousands of people. He viewed the Larkspur deaths as an acceptable cost—tragic but unavoidable. He would have documented everything not as a confession but as a justification. His notes would read like a researcher's journal, not a criminal's ledger."
"Would he testify?"
"If cornered, he would save himself. Bryce is not a true believer. He's a pragmatist who has convinced himself that his pragmatism is moral. Given a choice between prison and cooperation, he would cooperate. But you'd need leverage to corner him. You'd need his records."
Mercier stood up and walked to the window. Outside, the prison yard was empty—the inmates had been moved inside for the afternoon count. The sky was gray and low, threatening snow that the forecast said would not arrive.
"If I pursue this," she said, "I lose my career. Even if I find the evidence, even if it leads to prosecutions, I'll have obtained it outside of authorized channels. The cases could be thrown out. The Bureau could fire me. The defendants could sue me personally."
"Yes," Voss said. "Those are the stakes."
She turned back to face him. "What would you do?"
"I'm a felon serving a ten-year sentence for a crime I didn't commit. My judgment is demonstrably flawed. But I would find Bryce's server. I would make copies of everything. And then I would give it to someone who could not be silenced."
"Who?"
"A journalist. Someone with a byline and a lawyer and no institutional loyalty to anyone. The kind of person who publishes first and asks permission never."
Mercier thought of the letters Voss had written to the Atlanta Journal-Constitution. He had been thinking along these lines for weeks, building a parallel strategy while she was still trying to work within the system. The irony was not lost on her: the convicted felon had been more realistic about the limits of institutional justice than the FBI agent.
"Bryce lives in a gated community in Chapel Hill," she said. "If he has a personal server, it's in his house. I can't search his house without a warrant, and I can't get a warrant without probable cause."
"You don't need to search his house. You need to talk to his wife."
Mercier blinked. "His wife?"
"Anna Bryce. She filed for divorce six months ago. The proceedings are sealed, but the docket number is public record. She's been married to Leland for twenty-three years. She knows where he keeps things. And if she's divorcing him, she may have reasons to talk."
Mercier absorbed this. She had not known about the divorce. The information was not in any of the databases she had searched. Voss had found it somewhere—perhaps in the prison law library, perhaps through contacts she did not want to ask about.
"How do you know this?"
"The law library has access to certain public records databases. And I have a lot of time."
She nodded slowly. The clock on the wall showed four-thirty. Visiting hours ended at five. Outside the window, the first flakes of snow had begun to fall despite the forecast.
"One more question," she said. "Why did you tell Hirsch about Durham if you knew he would destroy it?"
"Because I needed him to act. A conspiracy that sits still is invisible. A conspiracy that moves leaves tracks. Hirsch moved. Now I know who he works for, how fast he can respond, and what he's willing to destroy. That's intelligence. You can't fight something you can't see."
Mercier gathered her coat and her notebook. She did not say goodbye. She simply nodded once, the way professionals acknowledge each other when words are insufficient, and walked out of the conference room.
The prison doors closed behind her with a heavy metallic sound. She stood in the parking lot, snow dusting her shoulders, and called the number for the field office in Raleigh.
"I need everything you have on Leland Bryce," she said. "Personal life, financials, property records, pending litigation. And I need a home address."
The analyst on the other end hesitated. "Agent Mercier, we received a memo this morning. The Kaelstrom inquiry is closed. I'm not supposed to—"
"I'm not calling about Kaelstrom. I'm calling about a divorce case. Marital assets. It's a personal matter."
The lie was thin, but the analyst did not challenge it. Thirty minutes later, Mercier had Bryce's address, the name of his divorce attorney, and the date of the next scheduled hearing in the divorce proceedings.
She drove to Chapel Hill through the gathering snow. The roads were still clear, but the edges of the highway were beginning to whiten. She checked into a motel near the university campus and spent the evening reviewing everything she had on Anna Bryce—her background, her employment history, her social media presence. She had been a high school biology teacher for fifteen years. She had no criminal record, no history of litigation, no visible connection to Kaelstrom beyond her marriage. She was, by all appearances, an ordinary woman in the process of ending a long marriage.
The next morning, Mercier dressed in civilian clothes—dark slacks, a wool coat, no visible badge or weapon—and drove to Anna Bryce's apartment complex on the outskirts of town. The building was modest, two stories, with a courtyard that had been decorated for Christmas. A wreath hung on every door.
Anna Bryce answered on the second knock. She was a thin woman in her late fifties, with gray-streaked hair and the wary eyes of someone who had been through something difficult and was not yet out the other side.
"Mrs. Bryce? My name is Eleanor Mercier. I'm an investigator looking into certain practices at Kaelstrom Biopharma. I'd like to ask you a few questions about your ex-husband."
"I'm not divorced yet."
"I know. I'm sorry. May I come in?"
Anna Bryce hesitated, then stepped aside. The apartment was small and neat, filled with the kind of furniture that suggested a life hastily reassembled. A cardboard box sat in the corner, half-filled with books.
"What did Leland do?" Anna asked. The question was direct, unflinching. It was the question of a woman who had been waiting for someone to ask.
"That's what I'm trying to determine. I have reason to believe that he was involved in clinical trials that were conducted without proper oversight. Trials that may have resulted in patient deaths."
Anna sat down on the sofa and folded her hands in her lap. "Leland always said someone would come eventually. He never said who. But he knew."
"Knew what?"
"That what he was doing would catch up with him. He didn't think of it as murder. He thought of it as science. The difference didn't seem to bother him until recently."
"Did he keep records?"
Anna looked at her for a long moment. Then she stood up, walked to a closet in the hallway, and returned with a small external hard drive. It was matte black, unremarkable, the kind of device that could be purchased at any electronics store.
"He kept this in a safe deposit box for years. When I filed for divorce, he moved it to the house. I found it in his study, hidden behind the drywall. I was looking for hidden assets. I found something else."
Mercier took the drive. It was heavier than it looked.
"Have you looked at what's on it?"
"Some of it. Enough to know that I don't want to be married to him anymore. Enough to know that he's not the man I thought I married."
Mercier slipped the drive into her coat pocket. Her heart was beating hard against her ribs, but her hands were steady. "Will you testify to where you found this?"
"I'll testify to whatever I have to. But you should know something. Leland is scared. He's been scared for months. He said there are people at the company who would do anything to keep this quiet. He wasn't threatening me. He was warning me."
"What kind of people?"
"He didn't give names. But he said they weren't scientists. He said they were the kind of people who solve problems permanently."
Mercier thought of Gerald Hirsch, the silver-haired lawyer who had visited Voss in prison. She thought of the Durham server, shredded within forty-eight hours of Martin Shore's death. She thought of the compassionate release motion, the offer of freedom in exchange for silence.
"Thank you," she said. "I'll be in touch."
She drove back to the motel through streets that were now white with snow. In her room, she plugged the hard drive into her laptop and began to read. The files were organized by date and project code. There were hundreds of them—emails, data tables, meeting minutes, pharmacokinetic analyses, adverse event reports. The earliest files dated back to the initial development of CX-903. The most recent were from four months ago, detailing the final formulation of Avantix.
And there, in a folder labeled "Larkspur Protocol," was the evidence. Enrollment records for forty-seven elderly patients across three nursing homes. Dosing schedules. Blood work results. And death certificates, annotated in Bryce's meticulous handwriting: "Subject 12—dose escalation tolerated to Day 14. Cardiac event Day 15. Autopsy declined per protocol. Metabolite levels consistent with therapeutic range. Conclusion: protocol endpoint achieved."
Protocol endpoint achieved. The phrase was so clinical, so detached from the reality it described. A human being had died, and Leland Bryce had recorded it as a data point.
Mercier sat in the dim light of the motel room, the snow falling silently outside the window, and read until her eyes burned. When she finished, she made three copies of the drive. One she mailed to herself at her home address. One she placed in a sealed envelope and deposited in a safe deposit box at a bank in downtown Chapel Hill. The third she kept in her pocket.
Then she called the journalist in Atlanta. The phone rang four times before a voice answered, groggy and irritated.
"This is Eleanor Mercier, FBI. I have a story for you. It's not a tip. It's a confession—from a dead man who didn't know he was making one."
Outside, the snow continued to fall, covering the streets of Chapel Hill in a clean white layer that hid the dirt and the cracks and the things that people preferred not to see.
No comments yet. Be the first to comment!